Klinische StudieMultizentrische StudieRandomisierte kontrollierte Studie
Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?
Nature Clinical Practice Cardiovascular Medicine · 2004
DOI: 10.1038/ncpcardio0006 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Nature Clinical Practice Cardiovascular Medicine, 2004. Verfasst von David J Maron. Beteiligte Einrichtung: Kim Dayani Center for Health Promotion at Vanderbilt University, Nashville, TN, USA. david.maron@vanderbilt.edu. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Acute DiseaseAdultAnticholesteremic AgentsCholesterol, HDLCholesterol, LDLFemaleFollow-Up StudiesHumansIncidenceMaleMyocardial IschemiaPravastatinRisk FactorsSurvival RateTreatment Outcome
Substanzen
Anticholesteremic AgentsCholesterol, HDLCholesterol, LDLPravastatin
Autor:innen und Institutionen
- Kim Dayani Center for Health Promotion at Vanderbilt University, Nashville, TN, USA. david.maron@vanderbilt.edu
Zitieren
APA
Maron, D. J. (2004). Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?. Nature Clinical Practice Cardiovascular Medicine. https://doi.org/10.1038/ncpcardio0006
Vancouver
Maron DJ. Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?. Nature Clinical Practice Cardiovascular Medicine. 2004. doi:10.1038/ncpcardio0006
BibTeX
@article{Maron2004,
author = {Maron, David J},
title = {Can pravastatin lower coronary event rate if HDL and LDL cholesterol are at low levels?},
journal = {Nature Clinical Practice Cardiovascular Medicine},
year = {2004},
doi = {10.1038/ncpcardio0006}
}
EUVIMED